专刊编辑寄语：新型乳腺癌治疗药物
Editorial for the Special Issue "New Drugs for Breast Cancer Treatment".
机构信息
Department of Sciences, University Roma Tre, Viale Guglielmo Marconi, 446, I-00146 Rome, Italy.
出版信息
Int J Mol Sci. 2022 Sep 6;23(18):10265. doi: 10.3390/ijms231810265.
Abstract
Breast cancer (BC) is the deadliest neoplastic disease for women worldwide [...].
摘要
乳腺癌（BC）是全球女性最致命的肿瘤疾病[...]。
相似文献
1
Editorial for the Special Issue "New Drugs for Breast Cancer Treatment".专刊编辑寄语：新型乳腺癌治疗药物
Int J Mol Sci. 2022 Sep 6;23(18):10265. doi: 10.3390/ijms231810265.
2
Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer.综述：美国食品药品监督管理局批准的针对乳腺癌女性的 MAPK 信号通路靶向药物。
Breast Dis. 2021;40(2):51-62. doi: 10.3233/BD-201063.
3
Breast cancer: An insight into its inflammatory, molecular, pathological and targeted facets with update on investigational drugs.乳腺癌：炎症、分子、病理和靶向方面的研究进展及在研药物更新。
Crit Rev Oncol Hematol. 2020 Oct;154:103070. doi: 10.1016/j.critrevonc.2020.103070. Epub 2020 Aug 29.
4
Identification of Hub Genes to Regulate Breast Cancer Spinal Metastases by Bioinformatics Analyses.基于生物信息学分析鉴定调控乳腺癌脊柱转移的枢纽基因。
Comput Math Methods Med. 2021 May 12;2021:5548918. doi: 10.1155/2021/5548918. eCollection 2021.
5
Predicting breast cancer drug response using a multiple-layer cell line drug response network model.利用多层细胞系药物反应网络模型预测乳腺癌药物反应。
BMC Cancer. 2021 May 31;21(1):648. doi: 10.1186/s12885-021-08359-6.
6
Recent Development in Indole Derivatives as Anticancer Agents for Breast Cancer.吲哚衍生物作为乳腺癌抗癌剂的最新研究进展。
Anticancer Agents Med Chem. 2019;19(8):962-983. doi: 10.2174/1871520619666190312125602.
7
Use of Trastuzumab for Neoadjuvant Therapy of HER2+ Breast Cancer - 5-Years of Experience in a Single Clinic.曲妥珠单抗用于HER2阳性乳腺癌新辅助治疗——单中心5年经验
Klin Onkol. 2018 Spring;31(3):191-199. doi: 10.14735/amko2018191.
8
Editorial Special Issue Section on Young Women and Breast Cancer. Monographic issue.社论 关于年轻女性与乳腺癌的特刊部分。专题 issue。 （这里“issue”直译为“期”，但结合语境，可能是想说“专题刊”，整体表述稍显不太准确，或许原文表述存在一些不严谨之处。）
Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:203. doi: 10.1016/j.ejogrb.2018.08.585. Epub 2018 Aug 29.
9
Ursolic acid a promising candidate in the therapeutics of breast cancer: Current status and future implications.熊果酸在乳腺癌治疗中的应用前景：现状与未来展望。
Biomed Pharmacother. 2018 Dec;108:752-756. doi: 10.1016/j.biopha.2018.09.096. Epub 2018 Sep 21.
10
Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer.诱导契合对接和自动化定量构效关系研究揭示了大麻在乳腺癌中对 ER-α 的抑制活性。
Recent Pat Anticancer Drug Discov. 2021;16(2):273-284. doi: 10.2174/1574892816666210201115359.
本文引用的文献
1
AB186 Inhibits Migration of Triple-Negative Breast Cancer Cells and Interacts with α-Tubulin.AB186 抑制三阴性乳腺癌细胞迁移并与微管蛋白 α 相互作用。
Int J Mol Sci. 2022 Jun 20;23(12):6859. doi: 10.3390/ijms23126859.
2
Untargeted LC-MS/MS Metabolomics Study on the MCF-7 Cell Line in the Presence of Valproic Acid.未靶向 LC-MS/MS 代谢组学研究丙戊酸存在下 MCF-7 细胞系。
Int J Mol Sci. 2022 Feb 28;23(5):2645. doi: 10.3390/ijms23052645.
3
New and Emerging Targeted Therapies for Advanced Breast Cancer.新型和新兴的晚期乳腺癌靶向治疗方法。
Int J Mol Sci. 2022 Feb 18;23(4):2288. doi: 10.3390/ijms23042288.
4
Inhibition of Carbonic Anhydrase IX Suppresses Breast Cancer Cell Motility at the Single-Cell Level.碳酸酐酶 IX 的抑制作用可抑制乳腺癌细胞在单细胞水平上的迁移。
Int J Mol Sci. 2021 Oct 26;22(21):11571. doi: 10.3390/ijms222111571.
5
Cytostatic Effect of a Novel Mitochondria-Targeted Pyrroline Nitroxide in Human Breast Cancer Lines.新型靶向线粒体吡咯烷硝酮类化合物对人乳腺癌细胞系的细胞抑制作用。
Int J Mol Sci. 2021 Aug 20;22(16):9016. doi: 10.3390/ijms22169016.
6
Breast Cancer and Anaesthesia: Genetic Influence.乳腺癌与麻醉：遗传影响。
Int J Mol Sci. 2021 Jul 17;22(14):7653. doi: 10.3390/ijms22147653.
7
Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells.光学氧化还原成像技术观察 Nampt 抑制剂单药及联合治疗三阴性乳腺癌细胞的治疗反应
Int J Mol Sci. 2021 May 25;22(11):5563. doi: 10.3390/ijms22115563.
8
Atovaquone Suppresses Triple-Negative Breast Tumor Growth by Reducing Immune-Suppressive Cells.阿托伐醌通过减少免疫抑制细胞来抑制三阴性乳腺癌肿瘤生长。
Int J Mol Sci. 2021 May 13;22(10):5150. doi: 10.3390/ijms22105150.
9
Theranostic Advances in Breast Cancer in Nuclear Medicine.核医学中乳腺癌的治疗与诊断进展
Int J Mol Sci. 2021 Apr 27;22(9):4597. doi: 10.3390/ijms22094597.
10
Antiplatelet Therapy Combined with Anastrozole Induces Features of Partial EMT in Breast Cancer Cells and Fails to Mitigate Breast-Cancer Induced Hypercoagulation.抗血小板治疗联合阿那曲唑诱导乳腺癌细胞部分 EMT 特征，并不能减轻乳腺癌引起的高凝状态。
Int J Mol Sci. 2021 Apr 16;22(8):4153. doi: 10.3390/ijms22084153.
Zotero 插件